학술논문
The combination of osimertinib with Raf inhibitor overcomes osimertinib resistance induced by KRAS amplification in EGFR-mutated lung cancer cells
Document Type
Article
Source
In Experimental Cell Research 1 September 2023 430(1)
Subject
Language
ISSN
0014-4827